ATPγS recycling opens cheaper pathways to increased drug stability
Researchers at Rice University have developed a more cost-effective method for adding thiophosphate to drug molecules. This breakthrough addresses the high costs associated with ATPγS, potentially making stable, phosphate-based pharmaceutical drugs more affordable to produce.
Why it matters
Reducing the cost of chemical synthesis for drug stability could accelerate the development of new, more effective medications for various diseases.
edited by Sadie Harley , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: Pixabay/CC0 Public Domain Pharmaceutical drugs often rely on chemical compounds found in the body. Take phosphate, a common compound cells use as a chemical switch. In a process called phosphorylation, cells can add a phosphate to a molecule and turn its function on. When the function is no longer needed, cells can remove the phosphate through dephosphorylation, turning the molecule back off.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in